Leukocyte-specific protein 1 targets the ERK/MAP kinase scaffold protein KSR and MEK1 and ERK2 to the actin cytoskeleton
- PMID: 15090600
- DOI: 10.1242/jcs.00955
Leukocyte-specific protein 1 targets the ERK/MAP kinase scaffold protein KSR and MEK1 and ERK2 to the actin cytoskeleton
Abstract
The identification and characterization of scaffold and targeting proteins of the ERK/MAP kinase pathway is important to understand the function and intracellular organization of this pathway. The F-actin binding protein leukocyte-specific protein 1 (LSP1) binds to PKCbetaI and expression of B-LSP1, an LSP1 truncate containing the PKCbetaI binding residues, inhibits anti-IgM-induced translocation of PKCbetaI to the plasma membrane and anti-IgM-induced activation of ERK2. To understand the role of LSP1 in the regulation of PKCbetaI-dependent ERK2 activation, we investigated whether LSP1 interacts with ERK/MAP kinase pathway components and targets these proteins to the actin cytoskeleton. We show that LSP1 associates with the ERK scaffold protein KSR and with MEK1 and ERK2. LSP1-associated MEK1 is activated by anti-IgM treatment and this activation is inhibited by expression of B-LSP1, suggesting that the activation of LSP1-associated MEK1 is PKCbetaI dependent. Confocal microscopy showed that LSP1 targets KSR, MEK1 and ERK2 to peripheral actin filaments. Thus our data show that LSP1 is a cytoskeletal targeting protein for the ERK/MAP kinase pathway and support a model in which MEK1 and ERK2 are organized in a cytoskeletal signaling complex together with KSR, PKCbetaI and LSP1 and are activated by anti-IgM in a PKCbetaI-dependent manner.
Similar articles
-
Implication of MEK1 and MEK2 in the establishment of the blood-placenta barrier during placentogenesis in mouse.Reprod Biomed Online. 2012 Jul;25(1):58-67. doi: 10.1016/j.rbmo.2012.02.012. Epub 2012 Mar 3. Reprod Biomed Online. 2012. PMID: 22561024 Review.
-
Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.Oncogene. 2007 Feb 8;26(6):813-21. doi: 10.1038/sj.onc.1209843. Epub 2006 Aug 7. Oncogene. 2007. PMID: 16909118
-
KSR--a regulator and scaffold protein of the MAPK pathway.Sci STKE. 2002 Jun 11;2002(136):pe28. doi: 10.1126/stke.2002.136.pe28. Sci STKE. 2002. PMID: 12060787 Review.
-
Inhibition of anti-IgM-induced translocation of protein kinase C beta I inhibits ERK2 activation and increases apoptosis.J Biol Chem. 2001 Jul 6;276(27):24506-10. doi: 10.1074/jbc.M103883200. Epub 2001 May 1. J Biol Chem. 2001. PMID: 11333276
-
The actin-binding protein, lymphocyte-specific protein 1, is expressed in human leukocytes and human myeloid and lymphoid cell lines.J Immunol. 1995 Oct 1;155(7):3563-9. J Immunol. 1995. PMID: 7561054
Cited by
-
Cyclosporine A Modulates LSP1 Protein Levels in Human B Cells to Attenuate B Cell Migration at Low O2 Levels.Life (Basel). 2022 Aug 22;12(8):1284. doi: 10.3390/life12081284. Life (Basel). 2022. PMID: 36013463 Free PMC article.
-
Lymphocyte-Specific Protein-1 Suppresses Xenobiotic-Induced Constitutive Androstane Receptor and Subsequent Yes-Associated Protein-Activated Hepatocyte Proliferation.Am J Pathol. 2022 Jun;192(6):887-903. doi: 10.1016/j.ajpath.2022.03.010. Epub 2022 Apr 4. Am J Pathol. 2022. PMID: 35390317 Free PMC article.
-
Lymphocyte-Specific Protein-1 Controls Sorafenib Sensitivity and Hepatocellular Proliferation through Extracellular Signal-Regulated Kinase 1/2 Activation.Am J Pathol. 2018 Sep;188(9):2074-2086. doi: 10.1016/j.ajpath.2018.06.005. Epub 2018 Jul 3. Am J Pathol. 2018. PMID: 30126548 Free PMC article.
-
The Phosphatidylinositol 3-Kinase Pathway as a Potential Therapeutic Target in Bladder Cancer.Clin Cancer Res. 2017 Nov 1;23(21):6580-6591. doi: 10.1158/1078-0432.CCR-17-0033. Epub 2017 Aug 14. Clin Cancer Res. 2017. PMID: 28808038 Free PMC article.
-
Lymphocyte-specific protein 1 inhibits the growth of hepatocellular carcinoma by suppressing ERK1/2 phosphorylation.FEBS Open Bio. 2016 Nov 7;6(12):1227-1237. doi: 10.1002/2211-5463.12139. eCollection 2016 Dec. FEBS Open Bio. 2016. Retraction in: FEBS Open Bio. 2022 Dec;12(12):2255. doi: 10.1002/2211-5463.13509. PMID: 28255535 Free PMC article. Retracted.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous